Related Experiment Video
Updated: Jan 25, 2026

Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
Rbfox2 dissociation from stress granules suppresses cancer progression
Sunkyung Choi1, Moa Sa2, Namjoon Cho1
1Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon, 34134, Republic of Korea.
Abstract:
Stress granules (SGs) are stalled translation initiation complexes comprising untranslated mRNAs and RNA-binding proteins (RBPs). RBP fox-1 homolog 2 (Rbfox2), a component of SGs, binds to retinoblastoma 1 (RB1) mRNA, which is closely related to cancer progression; however, the role of Rbfox2 in cancer progression remains largely unknown. In this study, we confirmed that Rbfox2, which is present in the nucleus as a splicing regulator, localizes to the cytoplasm of human colon cancer tissues and that induction of Rbfox2 dissociation from SGs by resveratrol treatment inhibits cancer progression. We also observed that Rbfox2 in SGs inhibited RB1 protein expression and promoted cell cycle progression. Additionally, resveratrol treatment inhibited SG-mediated Rbfox2 localization, further inhibiting RB1 protein expression, and inhibited specific Rbfox2 localization to the cytoplasm in melanoma B16-F10 cells, thereby effectively inhibiting metastasis and tumor growth ability. These results indicate that Rbfox2 dissociation from SGs attenuates cancer progression and offer insight into the mechanism associated with Rbfox2 dissociation, thereby marking Rbfox2 as a potential candidate target for cancer therapy.
Insights
Stress granules (SGs) sequester Rbfox2, inhibiting RB1 protein and promoting cancer. Resveratrol treatment dissociates Rbfox2 from SGs, reducing cancer progression and tumor growth.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- Stress granules (SGs) are cytoplasmic foci of stalled translation initiation complexes.
- RBP fox-1 homolog 2 (Rbfox2) is an SG component linked to cancer progression via RB1 mRNA.
- The precise role of Rbfox2 in cancer progression is not fully understood.
Purpose of the Study:
- To investigate the role of Rbfox2 in cancer progression.
- To elucidate the mechanism of Rbfox2 localization in stress granules.
- To evaluate the therapeutic potential of targeting Rbfox2 dissociation from SGs.
Main Methods:
- Immunohistochemical analysis of Rbfox2 localization in human colon cancer tissues.
- Treatment with resveratrol to induce Rbfox2 dissociation from SGs.
- Assessment of RB1 protein expression and cell cycle progression.
- In vivo studies using melanoma B16-F10 cells to evaluate metastasis and tumor growth.
Main Results:
- Rbfox2 localizes to the cytoplasm in human colon cancer tissues and within SGs.
- Rbfox2 in SGs inhibits RB1 protein expression and promotes cell cycle progression.
- Resveratrol treatment dissociates Rbfox2 from SGs, inhibiting RB1 expression and cancer progression.
- Resveratrol also inhibited Rbfox2 cytoplasmic localization in melanoma cells, reducing metastasis and tumor growth.
Conclusions:
- Rbfox2 dissociation from SGs attenuates cancer progression.
- Targeting Rbfox2 localization within SGs presents a potential therapeutic strategy for cancer.
- Rbfox2 is identified as a potential therapeutic target for cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Dissociative Disorders
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
Dissociative Amnesia
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Dissociative Identity Disorder
Responses to Salt Stress

